On Monday, Malin announced that one of the key companies in which it is invested, Kymab, is to be sold to French drugs giant Sanofi in a deal worth up to $1.45 billion (€1.2bn). Image: iStock

Almost six years after Malin Corp raised €330 million through an initial public offering (IPO) on the back of the reputation of its founders, a group (...)

Founded by Robert Fenton in 2012, Qualio has over 1,000 clients

Qualio, a software company founded and led by Irishman Robert Fenton, has raised $11 million (€9.6 million) and intends to create a large number of jo(...)

Poseida is a human therapeutics company using genome engineering technologies to develop treatments.

Poseida Therapeutics, a company in which Dublin-listed life-sciences investment group Malin has a significant stake, has announced the pricing of its (...)

Malin said it will not materially increase the last disclosed fair value estimate of its €111 million investment in Poseida

Poseida Therapeutics, a company in which Dublin-listed life-sciences investment group has a significant stake, has raised $110 million (€98 million) i(...)

Wall Street’s three major indices were higher in early afternoon trading as improving economic data and the prospect of more stimulus bolstered hopes of a swift recovery from Covid. Photograph: Michael Nagle/Bloomberg

European shares rose to their highest level in two weeks on Tuesday, with banks among the main gainers in Dublin, as investors piled into stocks that (...)

Malin is “optimistic that there will be a limited impact on its most important and potentially value-accretive clinical studies in 2020”. Photograph: Bloomberg

Irish life science investment company Malin Corp said it expected some brief delays in drug clinical trials being carried out by firms in which it is (...)

Immunocore is developing novel T cell receptor (TCR)-based therapies with the potential to treat a variety of cancers, viral infections and autoimmune diseases.

Immunocore, an Oxford-based biotech company in which Irish life-sciences investment company Malin has a 10 per cent stake, has raised more than $130 m(...)

Neil Woodford’s asset management company sold its stake in Malin.

US hedge fund Pentwater Capital has emerged as the buyer of the 23 per cent stake in Irish life science investment company Malin Corp that was sold in(...)

Life sciences company Malin is focused on four priority assets. Photograph: iStock

Troubled UK asset manager Woodford Investment Management sold its remaining 3.5 per cent stake in Irish life sciences company Malin this week, accordi(...)

Neil Woodford, known as  the ‘Oracle from Oxford. Photograph: Richard Cannon

For long-suffering investors in Irish life-sciences investment company Malin, having once-revered UK stock picker Neil Woodford in their corner helped(...)

  • 1
  • 2
  • Next
  • Last »